Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical impact of endoscopic ultrasound-guided through-the-needle microbiopsy in patients with pancreatic cysts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Reply to Firkins and Krishna

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  • Inna Markovna Chen
  • Nicholas Willumsen
  • Christian Dehlendorff
  • Astrid Zedlitz Johansen
  • Benny Vittrup Jensen
  • Carsten Palnaes Hansen
  • Jane Preuss Hasselby
  • Stig Egil Bojesen
  • Per Pfeiffer
  • Svend Erik Nielsen
  • Niels Henrik Holländer
  • Mette Karen Yilmaz
  • Morten Karsdal
  • Julia Sidenius Johansen
Vis graf over relationer

Hyaluronan (HA) and collagen are highly expressed in pancreatic cancer (PC) stroma. HA and collagen accumulation increase tumor interstitial fluid pressure, compromising blood flow and drug penetration. The aim of this biomarker study was to determine the clinical utility of serum HA and the propeptide of type III collagen (PRO-C3) in patients with PC. A cohort from the Danish BIOPAC study (NCT03311776) including patients with histologically confirmed pancreatic ductal adenocarcinoma (n = 809), ampullary carcinoma (n = 44), distal biliary tract cancer (n = 31), chronic pancreatitis (n = 15), intraductal papillary mucinous neoplasm (n = 41), duodenal adenoma (n = 7), and no cancer (n = 25). Healthy controls were available for serum HA (n = 141) and PRO-C3 (n = 8). The main outcome was overall survival (OS) of patients with PC in relation to pretreatment serum HA and PRO-C3 levels. Patients with PC had higher baseline serum HA and PRO-C3 than healthy subjects and patients with benign conditions. Pretreatment serum baseline HA and PRO-C3 in patients with PC were associated with poorer survival and PRO-C3 remained prognostic also after adjusting for age, performance status, stage, presence of liver and peritoneum metastasis, and CA19-9. Detection of HA and PRO-C3 may be useful in differentiating between malignant and benign pancreatic conditions. Serum HA and PRO-C3 were prognostic for OS in patients with PC. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cancer
Vol/bind146
Udgave nummer10
Sider (fra-til)2913-2922
Antal sider10
ISSN0020-7136
DOI
StatusUdgivet - 15 maj 2020

Bibliografisk note

This article is protected by copyright. All rights reserved.

ID: 58239950